company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2259000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1595000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3854000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3854000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,230000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-69000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-299000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4153000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4153000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4153000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1775000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5928000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.07
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.07
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1455000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 08:43:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.07
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1738000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2389000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4127000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4127000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-357000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-134000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-491000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4618000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4618000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4618000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1742000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6360000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.33
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.33
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1470000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:13:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.33
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3242000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4345000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7587000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7587000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1196000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1097000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-126000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2419000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10006000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10006000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10006000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1858000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11864000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.07
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.07
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1470000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 07:08:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.07
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4166000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11101000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15267000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15267000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-105000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-970000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-865000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16132000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16132000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16132000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2292000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18424000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1795000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1795000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1800000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:29:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5064000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15380000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20444000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20444000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,55000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20389000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20389000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20389000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-1000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20388000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9000000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,16.32
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9000000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,16.32
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9003000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,16.32
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6349000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14377000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20726000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20726000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,44000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20682000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20682000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20682000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20682000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32282000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32282000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q1,2014-01-01,2014-03-31,2015-07-28 16:21:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7570000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34707000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42277000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42277000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,72000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42205000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30785000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72990000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72990000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72990000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.19
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.19
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33373000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:51:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.19
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39575000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39575000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39575000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8812000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17105000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25917000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13658000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,73000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,73000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13731000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5179000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8552000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8552000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8552000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33531000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34859000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32900000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:12:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1684000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1684000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1684000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10656000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22196000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32852000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31168000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31140000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,512000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31652000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31652000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31652000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.94
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.93
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33258000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.94
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41678000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41678000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41678000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9584000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24557000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34141000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7537000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,125000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-52000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,73000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7610000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,974000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6636000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6636000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6636000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34154000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35239000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34900000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:56:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1597000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1597000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1597000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11959000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32059000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44018000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42421000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,139000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,218000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42203000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5072000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37131000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37131000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37131000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34400000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.08
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34400000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.08
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34353000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:54:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.08
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3448000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3448000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3448000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10412000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40479000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50891000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47443000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,320000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,339000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47104000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7531000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39573000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39573000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39573000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34700000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.14
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34700000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.14
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34782000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 16:09:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.14
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4782000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4782000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4782000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12066000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33917000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45983000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41201000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,387000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,394000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40807000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5158000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35649000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35649000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35649000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34580000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.03
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34580000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.03
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.03
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15721000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15721000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15721000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14696000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37770000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52466000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36745000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,446000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,476000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36269000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36301000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36301000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36301000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.03
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.03
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35256000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:12:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.03
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28198000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28198000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28198000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10489000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48262000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58751000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30553000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,446000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-98000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,348000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30205000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29905000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29945000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29945000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35392000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:43:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1668000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1668000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1668000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12024000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50854000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62878000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61210000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,409000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,389000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60821000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,100000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60921000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60891000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-60891000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35594000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.71
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35594000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.71
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35600000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:09:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.71
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5322000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5322000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5322000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12969000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59409000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72378000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67056000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,403000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,122000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,525000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66531000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-238000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66293000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66283000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-66283000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35486000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.86
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35486000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.86
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35500000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.86
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1662000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1662000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1662000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13159000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31979000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45138000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43476000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,378000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,357000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43119000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43122000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43122000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43122000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35900000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.2
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35900000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.2
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35804000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:12:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.2
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1661000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1661000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1661000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8552000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15657000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24209000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22548000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,344000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,343000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22205000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22204000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22204000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22204000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35800000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35800000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35858000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:30:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,206654000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,206654000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,206654000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7059000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10707000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17766000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,188888000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,391000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,379000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,189267000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,194000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,189073000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,189073000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,189073000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35971000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36047000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.25
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35900000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 09:08:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6913000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7946000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14859000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14859000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,409000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,409000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14450000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4908000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9542000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9542000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9542000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35919000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36007000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35900000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5645000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7686000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13331000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13331000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,473000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,457000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12874000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13074000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13073000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13073000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36153000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:05:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6332000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8516000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14848000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14848000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,602000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,602000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14246000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1000000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13246000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13209000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13209000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35700000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35700000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36188000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:03:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5968000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9407000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15375000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15375000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,637000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,636000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14739000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14739000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14745000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14745000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36000000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36000000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36202000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 06:32:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5667000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16128000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21795000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21795000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,677000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,125001000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,125678000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103883000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-263000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,104146000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,104114000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,104114000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37061000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.84
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37088000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.84
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37100000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.84
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5481000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7685000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13166000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13166000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,670000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,670000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12496000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12496000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12501000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12501000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41700000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41700000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41427000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5198000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10009000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15207000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15207000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,617000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,151000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,768000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14439000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14443000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14443000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14443000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41477000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:03:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4674000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10383000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15057000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15057000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,495000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,495000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14562000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-125000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14437000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14437000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14437000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41200000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41552000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 06:32:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6275000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11567000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17842000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17842000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,369000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,369000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17473000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17483000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17478000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17478000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42224000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42224000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
"IVERIC bio, Inc.",ISEE,549300GZXI59U71XPM70,0001410939,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
